Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) Return on Sales (2019 - 2026)

Profound Medical has reported Return on Sales over the past 7 years, most recently at 0.06% for Q4 2025.

  • For Q4 2025, Return on Sales rose 7.0% year-over-year to 0.06%; the TTM value through Dec 2025 reached 0.0%, up 3.0%, while the annual FY2025 figure was 0.0%, 3.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.06% at Profound Medical, up from 0.02% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.14% in Q4 2022 and troughed at 0.67% in Q4 2023.
  • A 5-year average of 0.04% and a median of 0.02% in 2021 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: plummeted -81bps in 2023 and later soared 66bps in 2024.
  • Year by year, Return on Sales stood at 0.51% in 2021, then soared by 127bps to 0.14% in 2022, then plummeted by -585bps to 0.67% in 2023, then skyrocketed by 98bps to 0.01% in 2024, then surged by 597bps to 0.06% in 2025.
  • Business Quant data shows Return on Sales for PROF at 0.06% in Q4 2025, 0.02% in Q3 2025, and 0.07% in Q2 2025.